Generating favorable growth factor and protease release profiles to enable extracellular matrix accumulation within an in vitro tissue engineering environment

• Published in: Acta biomaterialia Vol. 54; pp. 81 - 94
• Main Authors: Zhang, Xiaoqing, Battiston, Kyle G., Labow, Rosalind S., Simmons, Craig A., Santerre, J. Paul
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.05.2017; Elsevier BV
• Subjects: Accumulation; Bioaccumulation; Biomaterial; Cell culture; Co-culture; Coculture Techniques; Collagen; Collagenase 3; Collagenases - secretion; Connective tissues; Construction engineering; Cytokines; Cytokines - secretion; Degradation; Deposition; Elastin; Electrochemical machining; Extracellular matrix; Extracellular Matrix - chemistry; Gelatinase A; Gelatinase B; Growth factors; Humans; Immune system; In vitro methods and tests; In vivo methods and tests; Insulin; Insulin-like growth factor I; Matrix metalloproteinase; Monocytes; Monocytes - cytology; Monocytes - secretion; Muscle, Smooth, Vascular - cytology; Muscle, Smooth, Vascular - secretion; Myocytes, Smooth Muscle - cytology; Myocytes, Smooth Muscle - secretion; Polyurethane; Polyurethane resins; Protease; Proteinase; Regeneration; Scaffolds; Signaling; Smooth muscle; Studies; Tissue culture; Tissue Engineering; Underlying mechanisms; Vascular tissue; Extracellular matrix; Underlying mechanisms; Biomaterial; Matrix metalloproteinase; Co-culture
• ISSN: 1742-7061; 1878-7568
• DOI: 10.1016/j.actbio.2017.02.041

[Display omitted] Tissue engineering (particularly for the case of load-bearing cardiovascular and connective tissues) requires the ability to promote the production and accumulation of extracellular matrix (ECM) components (e.g., collagen, glycosaminoglycan and elastin). Although different approaches have been attempted in order to enhance ECM accumulation in tissue engineered constructs, studies of underlying signalling mechanisms that influence ECM deposition and degradation during tissue remodelling and regeneration in multi-cellular culture systems have been limited. The current study investigated vascular smooth muscle cell (VSMC)-monocyte co-culture systems using different VSMC:monocyte ratios, within a degradable polyurethane scaffold, to assess their influence on ECM generation and degradation processes, and to elucidate relevant signalling molecules involved in this in vitro vascular tissue engineering system. It was found that a desired release profile of growth factors (e.g. insulin growth factor-1 (IGF-1)) and hydrolytic proteases (e.g. matrix-metalloproteinases 2, 9, 13 and 14 (MMP2, MMP9, MMP13 and MMP14)), could be achieved in co-culture systems, yielding an accumulation of ECM (specifically for 2:1 and 4:1 VSMC:monocyte culture systems). This study has significant implications for the tissue engineering field (including vascular tissue engineering), not only because it identified important cytokines and proteases that control ECM accumulation/degradation within synthetic tissue engineering scaffolds, but also because the established culture systems could be applied to improve the development of different types of tissue constructs. Sufficient extracellular matrix accumulation within cardiovascular and connective tissue engineered constructs is a prerequisite for their appropriate function in vivo. This study established co-culture systems with tissue specific cells (vascular smooth muscle cells (VSMCs)) and defined ratios of immune cells (monocytes) to investigate extracellular matrix (ECM) generation and degradation processes, revealing important mechanisms underlying ECM turnover during vascular tissue regeneration/remodelling. A specific growth factor (IGF-1), as well as hydrolytic proteases (e.g. MMP2, MMP9, MMP13 and MMP14), were identified as playing important roles in these processes. ECM accumulation was found to be dependent on achieving a desired release profile of these ECM-promoting and ECM-degrading factors within the multi-cellular microenvironment. The findings enhance our understanding of ECM deposition and degradation during in vitro tissue engineering and would be applicable to the repair or regeneration of a variety of tissues.